Effects of Different Early Intensive Therapies on Long-term β-cell Function

PHASE4CompletedINTERVENTIONAL

Enrollment

264

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

CSII

continuous subcutaneous insulin infusion for 2\~4 weeks

DRUG

CSII, Metformin, Pioglitazone

CSII for 2\~4 weeks combined with metformin 1.5g/d and pioglitazone 30mg/d for 3 months.

DRUG

CSII, Sitagliptin

CSII for 2\~4 weeks combined with sitagliptin 100mg/d for 3 months

All Listed Sponsors

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

collaborator

Peking University Shenzhen Hospital

OTHER

collaborator

First People's Hospital of Foshan

OTHER

lead

Sun Yat-sen University

OTHER

NCT01471808 - Effects of Different Early Intensive Therapies on Long-term β-cell Function | Biotech Hunter | Biotech Hunter